Additionally, tumor-induced inflammatory cytokines, such as interleukin-6 (IL-6), had been implicated as key drivers of elevated platelet counts observed in cervical and ovarian cancer patients18, 40. This evidence concerns the gene IL6 and ovarian cancer.